Home/Filings/4/0001209191-18-028188
4//SEC Filing

Scranton Richard 4

Accession 0001209191-18-028188

CIK 0001396814other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 6:51 PM ET

Size

5.7 KB

Accession

0001209191-18-028188

Insider Transaction Report

Form 4
Period: 2018-05-02
Scranton Richard
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-05-02+20,00020,000 total
    Exercise: $34.38Exp: 2028-05-02Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.

Issuer

Pacira Pharmaceuticals, Inc.

CIK 0001396814

Entity typeother

Related Parties

1
  • filerCIK 0001709330

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:51 PM ET
Size
5.7 KB